The relationship between vascular endothelial growth factor (VEGF) and microalbuminuria in patients with essential hypertension

Internal Medicine

Volumn 47, Issue 17, 2008, Pages 1511-1516

  Ebinç, Fatma Ayerden ^a   Haksun, Ebinç ^b   Ülver, Derici Boztepe ^a   Koç, Eyüp ^a   Erten, Yasemin ^a   Altok, Kadriye Reis ^a   Bali, Musa ^a   Turgay, Arinsoy ^a   Sindel, Sükrü ^a  

^a GAZI UNIVERSITY   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Hypertension; Microalbuminuria; VEGF

Indexed keywords

CREATININE; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; MULTIPLE LINEAR REGRESSION ANALYSIS; PATHOGENESIS; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; UNIVARIATE ANALYSIS;

ADULT; ALBUMINURIA; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 56349135334     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1122     Document Type: Article

References (19)

1. Viazzi F, Leoncini G, Ratto E, et al. Microalbuminuria, blood pressure load, and systemic vascular permeability in primary hypertension. Am J Hypertens 19 (11): 1183-1189, 2006.
2. Asselbergs FW, de Boer RA, Diercks GF, et al. Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria? Int J Cardiol 93 (2-3): 211-215, 2004.
3. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 56 (3): 794-814, 1999.
4. Zhu X, Wu S, Dahut WL, Parikh CR, Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis. Am J Kidney Dis 49 (2): 186-193, 2007.
5. Belgore FM, Blann AD. Li-Saw-Hee FL. Beevers DG, Lip GY. Plasma levels of vascular endothelial growth Factor and its soluble receptor (SFlt-I) in essential hypertension. Am J Cardiol 87 (6): 805-807, 2001.
6. Tsai WC. Li YH, Huan YY, Lin CC, Chao TH. Chen JH. Plasma vascular endothelial growth factor as a member marker for early vascular damage in hypertension. Clin Sci 109 (1): 39-43, 2005.
7. Cha DR. Kim NH, Yoon JW, et al. Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int 77 Suppl: S104-S112. 2000.
8. Kim NH, Kim KB, Kim DL, et al. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus. Diabet Med 21 (6): 545-551, 2004.
9. Bortoloso E, Del Prete D. Dalla Vestra M. et al. Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes. Eur J Endocrinol 150 (6) 799-807, 2004.
10. Shimada K. Baba T. Neugebauer S. et al. Plasma vascular endothelial growth factor in Japanese Type 2 diabetic patients with and without nephropathy. J Diabetes Complications 16 (6): 386-390, 2002.
11. Khamaisi M, Schrijvers BF, De Vriese AS, Raz I, Flyvbjerg A. The emerging role of VEGF in diabetic kidney disease. Nephrol Dial Transplant 18 (8): 1427-4430, 2003.
12. Santilli F. Spagnoli A, Mohn A. et al. Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria. J Clin Endocrinol Metab 86 (8): 3971-3876, 2001.
13. Kim NH, Ch JH, Seo JA, et al. Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy. Kidney Int 67 (1): 167-177, 2005.
14. Cha DR. Kang YS, Han SY. et al. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats. J Endocrinol 183 (1): 183-194, 2004.
15. Hoshi S. Nomoto K. Kuromitsu J. Tomari S. Nagata M. High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem Biophys Res Commun 290 (1): 177-184, 2002.
16. Kim NH. Jung HH, Cha DR. Choi DS. Expresion of vascular endothelial growth factor in response to high glucose in rat mesangian cells. J endocrinol 165 (3): 617-624, 2000.
17. Lee SH. Wolf PL. Escudero R. Deutsch R. Jamieson SW. This-Hethwaite PA. Early expression of angiogenesis factors in acute myocardial ischaemia and infarction. N Engl J Med 342: 626-633, 2000.
18. Inoue M. Itoh H. Ueda M. et al. Vascular endothelial growth factor (VEG) expression in human coronary atherosclerotic lesions. Circulation 98: 2108-2116, 1998.
19. Flyvbjerg A. Putative pathophysiological role growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 43 (10): 1205-12123, 2000.